Drug Type Interferons, Biosimilar |
Synonyms Recombinant Human Interferon α2b(P.putida), 重组人干扰素α2b注射液(天津未名生物), 安福隆 + [1] |
Target |
Mechanism IFNAR agonists(Interferon alpha/beta receptor agonists), Immunostimulants, Innate antiviral immune response inducers |
Therapeutic Areas |
Active Indication |
Inactive Indication- |
Originator Organization |
Active Organization |
Inactive Organization- |
Drug Highest PhaseApproved |
First Approval Date CN (01 Jan 1997), |
Regulation- |
KEGG | Wiki | ATC | Drug Bank |
---|---|---|---|
- | - | - |
Indication | Country/Location | Organization | Date |
---|---|---|---|
AIDS-related Kaposi Sarcoma | CN | 01 Jan 1997 | |
Chronic Myelogenous Leukemia | CN | 01 Jan 1997 | |
Condylomata Acuminata | CN | 01 Jan 1997 | |
Hairy Cell Leukemia | CN | 01 Jan 1997 | |
Hepatitis B, Chronic | CN | 01 Jan 1997 | |
Hepatitis C, Chronic | CN | 01 Jan 1997 | |
Lymphoma | CN | 01 Jan 1997 | |
Melanoma | CN | 01 Jan 1997 | |
Neoplasms | CN | 01 Jan 1997 | |
Virus Diseases | CN | 01 Jan 1997 |